back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-10 17:44 Tx date 2024-04-05 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+60,000 vol |
142,500 | |
| Filed 2024-04-10 17:43 Tx date 2024-04-05 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-60,000 vol |
0 | |
| Filed 2023-12-04 16:37 Tx date 2023-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+133,333 vol |
239,380 | |
| Filed 2023-12-04 16:36 Tx date 2023-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-133,333 vol |
266,667 | |
| Filed 2023-09-29 16:21 Tx date 2023-09-29 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+20,245 vol |
760,336 | |
| Filed 2023-09-29 16:20 Tx date 2023-09-29 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-20,245 vol |
20,244 | |
| Filed 2023-06-09 16:34 Tx date 2023-06-06 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+30,000 vol |
60,000 | |
| Filed 2023-06-09 16:32 Tx date 2023-06-06 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-30,000 vol |
0 | |
| Filed 2023-03-31 16:44 Tx date 2023-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-446,000
-100,000 vol $4.46 each |
100,000 | |
| Filed 2023-01-04 17:45 Tx date 2022-12-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+6,047 vol |
106,047 | |
| Filed 2023-01-04 17:42 Tx date 2022-12-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,047 vol |
400,000 | |
| Filed 2023-01-04 17:18 Tx date 2022-12-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+6,047 vol |
406,047 | |
| Filed 2023-01-04 17:15 Tx date 2022-12-30 |
$CRDL
Cardiol Therapeutics Inc. |
Lim, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+14,323 vol |
438,990 | |
| Filed 2023-01-04 17:11 Tx date 2022-12-30 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,185 vol |
563,891 | |
| Filed 2022-12-02 20:14 Tx date 2022-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+80,991 vol |
740,091 | |
| Filed 2022-12-02 20:12 Tx date 2022-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-80,991 vol |
40,489 | |
| Filed 2022-12-02 20:08 Tx date 2022-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
57 - Exercise of rights
|
+30,000 vol |
30,000 | |
| Filed 2022-12-02 20:06 Tx date 2022-11-29 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-30,000 vol |
30,000 | |
| Filed 2022-11-30 15:31 Tx date 2022-05-19 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-05 18:18 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-195,600
-60,000 vol $3.26 each |
60,000 | |
| Filed 2022-10-05 18:17 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$84,600
+60,000 vol $1.41 each |
60,000 | |
| Filed 2022-10-05 18:15 Tx date 2022-05-19 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-05 18:13 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-300,000
-60,000 vol $5.00 each |
0 | |
| Filed 2022-10-05 18:12 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$96,101
+68,157 vol $1.41 each |
68,157 | |
| Filed 2022-10-05 18:10 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-05 18:08 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-195,600
-60,000 vol $3.26 each |
200,000 | |
| Filed 2022-10-05 18:06 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-221,400
-60,000 vol $3.69 each |
260,000 | |
| Filed 2022-10-05 18:05 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$171,286
+121,480 vol $1.41 each |
121,480 | |
| Filed 2022-10-05 18:03 Tx date 2021-09-07 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-05 18:02 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-300,000
-60,000 vol $5.00 each |
0 | |
| Filed 2022-10-05 17:59 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$96,101
+68,157 vol $1.41 each |
68,157 | |
| Filed 2022-10-05 17:57 Tx date 2018-08-21 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-05 17:54 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-244,800
-60,000 vol $4.08 each |
0 | |
| Filed 2022-10-05 17:53 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$84,600
+60,000 vol $1.41 each |
60,000 | |
| Filed 2022-10-05 17:51 Tx date 2019-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-05 17:48 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
0 | |
| Filed 2022-10-05 17:46 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$783,545
+555,706 vol $1.41 each |
555,706 | |
| Filed 2022-10-05 17:43 Tx date 2018-08-16 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-05 17:41 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Lim, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-400,000 vol |
0 | |
| Filed 2022-10-05 17:39 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Lim, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$598,780
+424,667 vol $1.41 each |
424,667 | |
| Filed 2022-10-05 17:35 Tx date 2020-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Lim, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-05 17:31 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-400,000 vol |
0 | |
| Filed 2022-10-05 17:27 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$564,000
+400,000 vol $1.41 each |
400,000 | |
| Filed 2022-10-05 17:23 Tx date 2021-03-29 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-07-08 16:06 Tx date 2022-07-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-600,000 vol |
1,154,500 | |
| Filed 2022-06-24 16:47 Tx date 2022-06-23 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
OTC Calls (including Private Options to Purchase) 250,000 common shares expires June 2022
73 - Expiration of third party derivative
|
+1 vol |
0 | |
| Filed 2022-05-29 18:42 Tx date 2022-05-19 |
$CRDL
Cardiol Therapeutics Inc. |
Loxam, Teri
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
120,000 | ||
| Filed 2022-04-04 18:27 Tx date 2022-03-31 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$68,544
+47,000 vol $1.46 each |
89,164 | |
| Filed 2022-04-04 17:12 Tx date 2022-03-30 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$28,484
+19,800 vol $1.44 each |
42,164 | |
| Filed 2022-03-17 16:53 Tx date 2022-03-15 |
$CRDL
Cardiol Therapeutics Inc. |
Chao, Jennifer
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2021-12-14 18:38 Tx date 2021-12-09 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$397,500
+150,000 vol $2.65 each |
500,000 | |
| Filed 2021-12-14 18:32 Tx date 2021-12-09 |
$CRDL
Cardiol Therapeutics Inc. |
Lim, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$477,000
+180,000 vol $2.65 each |
400,000 | |
| Filed 2021-12-14 17:52 Tx date 2021-12-09 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,166,750
+325,000 vol $3.59 each |
325,000 | |
| Filed 2021-12-14 17:49 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-10-14 11:55 Tx date 2021-10-12 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Indirect Ownership)
|
Common Shares (Class A)
54 - Exercise of warrants
|
$65,000
+20,000 vol $3.25 each |
460,000 | |
| Filed 2021-10-14 11:51 Tx date 2021-10-12 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-65,000
-20,000 vol $3.25 each |
0 | |
| Filed 2021-10-04 09:25 Tx date 2021-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
46 - Compensation for services
|
$24,715
+4,336 vol $5.70 each |
22,364 | |
| Filed 2021-10-03 13:20 Tx date 2021-09-28 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-50,000 vol |
659,100 | |
| Filed 2021-09-15 10:08 Tx date 2021-08-25 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
46 - Compensation for services
|
$11,257
+3,496 vol $3.22 each |
18,028 | |
| Filed 2021-09-14 20:25 Tx date 2021-09-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-200,000 vol |
1,754,500 | |
| Filed 2021-09-12 17:52 Tx date 2021-09-07 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
320,000 | ||
| Filed 2021-09-12 17:50 Tx date 2021-09-07 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Holder: Allendale KOP Investments, LP (Indirect Ownership)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
11,000 | ||
| Filed 2021-09-12 17:49 Tx date 2021-09-07 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Holder: Willner Properties Services, Inc. (Indirect Ownership)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
15,005 | ||
| Filed 2021-09-12 17:47 Tx date 2021-09-07 |
$CRDL
Cardiol Therapeutics Inc. |
Willner, Michael Jay
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
709,100 | ||
| Filed 2021-05-25 17:06 Tx date 2021-05-25 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
$-48,000
-15,000 vol $3.20 each |
1,954,500 | |
| Filed 2021-04-16 16:43 Tx date 2021-04-12 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
46 - Compensation for services
|
$423,000
+100,000 vol $4.23 each |
100,000 | |
| Filed 2021-04-05 10:19 Tx date 2021-03-31 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
46 - Compensation for services
|
$11,250
+2,478 vol $4.54 each |
14,532 | |
| Filed 2021-04-04 13:48 Tx date 2021-03-30 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,804,000
+400,000 vol $4.51 each |
400,000 | |
| Filed 2021-04-04 13:44 Tx date 2021-03-29 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-04 13:43 Tx date 2021-03-29 |
$CRDL
Cardiol Therapeutics Inc. |
Hamer, Andrew Warwick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-02 21:41 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
34,000 | |
| Filed 2021-03-02 21:35 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
0 | |
| Filed 2021-03-02 21:30 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
||
| Filed 2021-03-02 21:29 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
||
| Filed 2021-03-02 20:47 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
-10,000 | |
| Filed 2021-03-02 20:47 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
||
| Filed 2021-03-02 20:42 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
||
| Filed 2021-03-02 20:42 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
1,250,000 | |
| Filed 2021-03-01 17:18 Tx date 2021-02-24 |
$CRDL
Cardiol Therapeutics Inc. |
Lim, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$32,500
+10,000 vol $3.25 each |
30,000 | |
| Filed 2021-03-01 17:16 Tx date 2021-02-24 |
$CRDL
Cardiol Therapeutics Inc. |
Lim, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-32,500
-10,000 vol $3.25 each |
0 | |
| Filed 2021-03-01 17:13 Tx date 2020-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Lim, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
220,000 | ||
| Filed 2021-03-01 17:12 Tx date 2020-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Lim, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
| Filed 2021-03-01 17:10 Tx date 2020-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Lim, Bernard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
| Filed 2021-02-26 17:44 Tx date 2021-02-25 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$99,450
+22,500 vol $4.42 each |
82,500 | |
| Filed 2021-02-26 17:41 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$65,000
+20,000 vol $3.25 each |
60,000 | |
| Filed 2021-02-26 17:37 Tx date 2021-02-22 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-65,000
-20,000 vol $3.25 each |
0 | |
| Filed 2021-02-11 13:40 Tx date 2021-01-11 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
46 - Compensation for services
|
$33,751
+12,054 vol $2.80 each |
12,054 | |
| Filed 2021-02-11 13:38 Tx date 2018-08-21 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-10 20:09 Tx date 2021-02-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
$-190,001.50
-58,462 vol $3.25 each |
1,969,500 | |
| Filed 2021-02-10 20:06 Tx date 2021-02-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$190,001
+58,462 vol $3.25 each |
2,027,962 | |
| Filed 2021-02-10 20:03 Tx date 2021-02-10 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-190,001.50
-58,462 vol $3.25 each |
0 | |
| Filed 2021-02-10 19:57 Tx date 2021-02-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
$-199,998.50
-61,538 vol $3.25 each |
1,969,500 | |
| Filed 2021-02-10 19:53 Tx date 2021-02-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
54 - Exercise of warrants
|
$199,998
+61,538 vol $3.25 each |
2,031,038 | |
| Filed 2021-02-10 19:47 Tx date 2021-02-05 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-199,998.50
-61,538 vol $3.25 each |
58,462 | |
| Filed 2020-08-20 18:02 Tx date 2020-08-20 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-990,000 vol |
1,969,500 | |
| Filed 2020-06-29 17:08 Tx date 2020-06-28 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
OTC Calls (including Private Options to Purchase) 250,000 common shares expires June 2022
70 - Acquisition or disposition (writing) of third party derivative
|
$-10.00
-1 vol $10.00 each |
-1 | |
| Filed 2020-06-29 16:01 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
OTC Calls (including Private Options to Purchase) 250,000 common shares expires June 2022
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-08 12:14 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$2,200
+10,000 vol $0.22 each |
10,000 | |
| Filed 2020-06-08 12:04 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-08 11:51 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Indirect Ownership)
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$47,800
+20,000 vol $2.39 each |
24,000 | |
| Filed 2020-06-05 17:27 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$4,400
+20,000 vol $0.22 each |
20,000 | |
| Filed 2020-06-05 17:23 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-05 17:22 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Indirect Ownership)
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$95,600
+40,000 vol $2.39 each |
440,000 | |
| Filed 2020-06-05 17:16 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$4,400
+20,000 vol $0.22 each |
20,000 | |
| Filed 2020-06-05 17:10 Tx date 2019-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-05 17:09 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$95,600
+40,000 vol $2.39 each |
40,000 | |
| Filed 2020-06-05 17:08 Tx date 2019-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-05 15:58 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$26,400
+120,000 vol $0.22 each |
120,000 | |
| Filed 2020-06-05 15:55 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-05 15:48 Tx date 2020-06-04 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$573,600
+240,000 vol $2.39 each |
2,959,500 | |
| Filed 2020-05-01 11:05 Tx date 2019-10-29 |
$CRDL
Cardiol Therapeutics Inc. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$1,864
+550 vol $3.39 each |
7,450 | |
| Filed 2020-05-01 11:03 Tx date 2019-10-28 |
$CRDL
Cardiol Therapeutics Inc. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$23,048
+6,900 vol $3.34 each |
6,900 | |
| Filed 2020-05-01 11:01 Tx date 2018-08-20 |
$CRDL
Cardiol Therapeutics Inc. |
Brown, Deborah
4 - Director of Issuer
Holder: 2578606 Ontario Inc. (Indirect Ownership)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-03 16:51 Tx date 2020-02-24 |
$CRDL
Cardiol Therapeutics Inc. |
Moffatt, John Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$70,800
+20,000 vol $3.54 each |
80,000 | |
| Filed 2019-12-09 12:11 Tx date 2019-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$244,800
+60,000 vol $4.08 each |
60,000 | |
| Filed 2019-12-09 12:07 Tx date 2019-12-03 |
$CRDL
Cardiol Therapeutics Inc. |
Stott, Colin George
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-23 09:26 Tx date 2019-10-17 |
$CRDL
Cardiol Therapeutics Inc. |
Chalmers, Iain
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$1,950
+600 vol $3.25 each |
600 | |
| Filed 2019-10-18 13:54 Tx date 2019-10-17 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$10,753
+3,090 vol $3.48 each |
3,090 | |
| Filed 2019-10-18 13:52 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-16 15:24 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$2,880
+1,000 vol $2.88 each |
2,719,500 | |
| Filed 2019-10-16 15:23 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$5,529
+1,900 vol $2.91 each |
2,718,500 | |
| Filed 2019-10-16 15:22 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$287.00
+100 vol $2.87 each |
2,716,600 | |
| Filed 2019-10-16 15:22 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$1,360
+500 vol $2.72 each |
2,716,500 | |
| Filed 2019-10-16 15:21 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$1,370
+500 vol $2.74 each |
2,716,000 | |
| Filed 2019-10-16 15:20 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$2,750
+1,000 vol $2.75 each |
2,715,500 | |
| Filed 2019-10-16 15:19 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$5,700
+2,000 vol $2.85 each |
2,714,500 | |
| Filed 2019-10-16 15:18 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$7,300
+2,500 vol $2.92 each |
2,712,500 | |
| Filed 2019-10-16 14:33 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$27,200
+10,000 vol $2.72 each |
110,000 | |
| Filed 2019-10-15 17:06 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$468.00
+200 vol $2.34 each |
2,710,000 | |
| Filed 2019-10-15 17:05 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$1,764
+700 vol $2.52 each |
2,709,800 | |
| Filed 2019-10-15 17:05 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$520.00
+200 vol $2.60 each |
2,709,100 | |
| Filed 2019-10-15 17:04 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$259.00
+100 vol $2.59 each |
2,708,900 | |
| Filed 2019-10-15 17:04 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$4,626
+1,800 vol $2.57 each |
2,708,800 | |
| Filed 2019-10-15 17:03 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$5,566
+2,200 vol $2.53 each |
2,707,000 | |
| Filed 2019-10-15 16:39 Tx date 2019-10-11 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$11,376
+4,800 vol $2.37 each |
2,704,800 | |
| Filed 2019-10-15 14:55 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Control or Direction)
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$10,840
+4,000 vol $2.71 each |
4,000 | |
| Filed 2019-10-15 14:53 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Holder: Eldon R Smith & Associates Ltd (Control or Direction)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-10 14:36 Tx date 2019-04-05 |
$CRDL
Cardiol Therapeutics Inc. |
Chalmers, Iain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$325,200
+60,000 vol $5.42 each |
120,000 | |
| Filed 2019-04-04 11:46 Tx date 2019-04-02 |
$CRDL
Cardiol Therapeutics Inc. |
Moffatt, John Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,200
+60,000 vol $5.77 each |
60,000 | |
| Filed 2019-04-04 11:35 Tx date 2019-03-06 |
$CRDL
Cardiol Therapeutics Inc. |
Moffatt, John Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-12 Tx date 2019-03-06 |
$CRDL
Cardiol Therapeutics Inc. |
Moffatt, John Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
| Filed 2019-03-12 Tx date 2019-03-06 |
$CRDL
Cardiol Therapeutics Inc. |
Moffatt, John Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
| Filed 2019-02-25 Tx date 2019-02-20 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$-64,000
-40,000 vol $1.60 each |
0 | |
| Filed 2019-02-25 Tx date 2019-02-20 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$-64,000
-40,000 vol $1.60 each |
||
| Filed 2019-02-22 Tx date 2019-02-20 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
47 - Acquisition or disposition by gift
|
-300,000 vol |
2,700,000 | |
| Filed 2019-02-21 Tx date 2019-02-20 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$-64,000
-40,000 vol $1.60 each |
0 | |
| Filed 2019-02-06 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: Peter Pekos RRSP (Indirect Ownership)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-02-06 Tx date 2019-02-04 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: Peter Pekos RRSP (Indirect Ownership)
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$19,950
+2,800 vol $7.13 each |
2,800 | |
| Filed 2019-02-06 Tx date 2019-02-04 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: Natalie Lazarowych RRSP (Control or Direction)
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$10,010
+1,400 vol $7.15 each |
1,400 | |
| Filed 2019-02-06 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: Natalie Lazarowych RRSP (Control or Direction)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-04 Tx date 2019-01-03 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$645,000
+150,000 vol $4.30 each |
350,000 | |
| Filed 2018-12-27 Tx date 2018-12-18 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
15 - Acquisition or disposition under a prospectus
|
$200,000
+40,000 vol $5.00 each |
1,240,000 | |
| Filed 2018-12-27 Tx date 2018-12-18 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+40,000 vol |
40,000 | |
| Filed 2018-12-27 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-27 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-27 Tx date 2018-12-18 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-27 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
11 - Acquisition or disposition carried out privately
|
$6,000
+600,000 vol $0.01 each |
600,000 | |
| Filed 2018-12-27 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-27 Tx date 2018-08-28 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
37 - Stock split or consolidation
|
+600,000 vol |
1,200,000 | |
| Filed 2018-12-26 Tx date 2018-12-18 |
$CRDL
Cardiol Therapeutics Inc. |
Smith, Eldon
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-24 Tx date 2018-08-21 |
$CRDL
Cardiol Therapeutics Inc. |
Torre, Guillermo
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2018-12-24 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Holder: 838447 Ontario Inc. (Control or Direction)
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2018-12-24 Tx date 2018-12-20 |
$CRDL
Cardiol Therapeutics Inc. |
Lynch, Terry
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
1,200,000 | ||
| Filed 2018-12-21 Tx date 2017-12-15 |
$CRDL
Cardiol Therapeutics Inc. |
PEKOS, PETER
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2018-12-21 Tx date 2018-08-21 |
$CRDL
Cardiol Therapeutics Inc. |
Chalmers, Iain
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2018-12-21 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Bolton, Anthony Ernest
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
1,200,000 | ||
| Filed 2018-12-21 Tx date 2018-08-21 |
$CRDL
Cardiol Therapeutics Inc. |
Chalmers, Iain
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-08-16 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2018-12-21 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Bolton, Anthony Ernest
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2017-01-19 |
$CRDL
Cardiol Therapeutics Inc. |
Elsley, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
3,000,000 | ||
| Filed 2018-12-21 Tx date 2018-08-20 |
$CRDL
Cardiol Therapeutics Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2018-12-21 Tx date 2018-08-20 |
$CRDL
Cardiol Therapeutics Inc. |
Brown, Deborah
4 - Director of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-21 Tx date 2018-08-16 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 |